Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Nanovibronix Inc
(NQ:
NAOV
)
0.6795
+0.0295 (+4.54%)
Streaming Delayed Price
Updated: 10:16 AM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,961
Open
0.6260
Bid (Size)
0.6390 (14)
Ask (Size)
0.6896 (90)
Prev. Close
0.6500
Today's Range
0.6260 - 0.6898
52wk Range
0.4575 - 1.520
Shares Outstanding
3,752,354
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
NanoVibronix Provides Business Update
November 12, 2024
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany
October 09, 2024
From
NanoVibronix, Inc.
Via
Business Wire
Performance
YTD
-40.91%
-40.91%
1 Month
+23.77%
+23.77%
3 Month
+18.17%
+18.17%
6 Month
-8.79%
-8.79%
1 Year
-50.04%
-50.04%
More News
Read More
NanoVibronix Signs Letter of Intent with Potential New Distributor
September 23, 2024
From
NanoVibronix, Inc.
Via
Business Wire
NAOV Stock Earnings: NanoVibronix Reported Results for Q2 2024
August 15, 2024
Via
InvestorPlace
NAOV Stock Earnings: NanoVibronix Reported Results for Q1 2024
May 15, 2024
Via
InvestorPlace
NAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023
April 10, 2024
Via
InvestorPlace
NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders
August 21, 2024
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan
May 22, 2024
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Issues Letter to Stockholders
May 16, 2024
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield
May 14, 2024
From
NanoVibronix, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 03, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 03, 2024
Via
InvestorPlace
Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
May 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 01, 2024
Via
Benzinga
NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award
May 01, 2024
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Issues Letter to Stockholders
April 09, 2024
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
March 28, 2024
From
NanoVibronix, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
January 29, 2024
Via
Benzinga
NanoVibronix Featured in Your Bladder Health Magazine
December 06, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity
December 04, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
November 28, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Regains Nasdaq Compliance
November 21, 2023
From
NanoVibronix, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
November 20, 2023
Via
Benzinga
NanoVibronix Issues Letter to Shareholders
November 14, 2023
From
NanoVibronix, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 10, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.